Document is current
Any future updates will be listed below
-
Authors
Ahmed, Yasmin
Nguyen, Binh An https://orcid.org/0000-0001-7055-8809
Kelly, Candace
Afrin, Shumaila
Singh, Virender https://orcid.org/0000-0002-6720-8784
Evers, Bret M. https://orcid.org/0000-0001-5686-0315
Shelton, John M. https://orcid.org/0000-0002-2949-1638
Lopez Escobar, Christian https://orcid.org/0009-0005-1820-0144
Singh, Preeti https://orcid.org/0000-0003-2508-5613
Pedretti, Rose
Wang, Lanie
Bassett, Parker https://orcid.org/0009-0001-5162-7212
Fernandez-Ramirez, Maria del Carmen https://orcid.org/0000-0002-3265-5242
Pekala, Maja
Lemoff, Andrew https://orcid.org/0000-0002-4943-0170
Kluve-Beckerman, Barbara
Saelices, Lorena https://orcid.org/0000-0002-1904-2150
-
Funding
Funding for this research was provided by:
American Heart Association (847236)
Welch Foundation (I-2121-20220331)
UTSW Endowment, Distinguished Researcher Award from President’s Research Council and start-up funds
- License Information
-
More Information
Article History
Received: 8 February 2025
Accepted: 12 March 2026
First Online: 1 April 2026
Competing interests
: L.S. reports research funding from NHLBI, UTSW, and AstraZeneca. L.S. also reports advisory board and/or consulting fees from Pfizer. L.S, R.P., and B.A.N. are co-founders of AmyGo. The rest of the authors report no conflicts of interest.
